tiprankstipranks
Trending News
More News >
Ship Healthcare Holdings (JP:3360)
:3360

Ship Healthcare Holdings (3360) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Ship Healthcare Holdings

(OTC:3360)

Rating:68Neutral
Price Target:
¥1,966.00
▲(1.34%Upside)
Ship Healthcare Holdings demonstrates strong financial health, with consistent revenue growth and improved leverage, providing a solid foundation for future growth. However, technical indicators show bearish trends and weak momentum, which could pose short-term challenges. The attractive valuation offers potential upside, making it a mixed but promising opportunity in the medical instruments and supplies sector.

Ship Healthcare Holdings (3360) vs. iShares MSCI Japan ETF (EWJ)

Ship Healthcare Holdings Business Overview & Revenue Model

Company DescriptionShip Healthcare Holdings Inc. (3360) is a Japan-based company primarily engaged in the provision of comprehensive healthcare services and products. The company operates through several segments, including Medical Supply, Lifecare, Dispensing Pharmacy, and Others. Ship Healthcare Holdings offers medical equipment and supplies, constructs and manages healthcare facilities, operates nursing homes and elderly care facilities, and provides dispensing pharmacy services. Additionally, the company is involved in various healthcare-related businesses, aiming to enhance the quality of life and healthcare standards.
How the Company Makes MoneyShip Healthcare Holdings generates revenue through a diversified business model that encompasses multiple segments within the healthcare industry. The Medical Supply segment is a key revenue stream, involving the sale and distribution of medical equipment and supplies to hospitals and healthcare institutions. The Lifecare segment contributes by operating nursing homes and elderly care facilities, providing residential and day-care services for seniors. The Dispensing Pharmacy segment adds to revenue by operating pharmacies that offer prescription medications and healthcare products. Furthermore, the company engages in the construction and management of healthcare facilities, which includes partnerships with medical institutions for facility development and operation. These activities, combined with various healthcare-related services, form the core revenue streams for Ship Healthcare Holdings.

Ship Healthcare Holdings Financial Statement Overview

Summary
Ship Healthcare Holdings displays a robust financial performance with consistent revenue growth, strong profit margins, and effective cash flow management. The reduced leverage and improved return on equity enhance its financial stability, positioning the company well for future growth.
Income Statement
85
Very Positive
Ship Healthcare Holdings has demonstrated robust revenue growth over the years, with a notable increase from 514.35 billion yen in 2022 to 678.23 billion yen in 2025. The gross profit margin remains stable at around 10%, and the net profit margin improved to approximately 2.23% in 2025. EBIT and EBITDA margins have been consistent, contributing to overall profitability. The company's ability to grow revenue consistently highlights its strong market position and effective business strategy.
Balance Sheet
78
Positive
The balance sheet of Ship Healthcare Holdings shows a healthy equity position, with a debt-to-equity ratio improving from 0.61 in 2020 to 0.25 in 2025, indicating reduced leverage and risk. The equity ratio remains strong, reflecting financial stability. Return on equity has improved, suggesting efficient use of shareholder funds. However, the reduction in cash reserves over time and the presence of debt warrants ongoing monitoring.
Cash Flow
80
Positive
Operating cash flow remains strong, supporting the company's operational needs. Despite fluctuations, free cash flow has shown positive growth, with a notable increase from 8.96 billion yen in 2022 to 16.56 billion yen in 2025. The operating cash flow to net income ratio is favorable, indicating effective cash management. While capital expenditures are well-managed, continuous monitoring of financing activities is recommended.
Breakdown
TTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income StatementTotal Revenue
670.20B678.23B630.99B572.28B514.35B497.16B
Gross Profit
66.22B66.74B65.61B60.62B53.64B54.49B
EBIT
24.53B24.79B24.54B21.14B20.50B21.80B
EBITDA
33.16B32.19B29.75B28.61B26.23B26.30B
Net Income Common Stockholders
17.08B15.13B13.79B12.06B12.17B12.28B
Balance SheetCash, Cash Equivalents and Short-Term Investments
72.96B77.50B85.07B83.94B77.44B77.26B
Total Assets
378.43B381.70B386.82B381.98B335.07B334.50B
Total Debt
33.83B37.34B57.93B73.94B61.22B64.96B
Net Debt
-39.13B-40.16B-27.14B-6.90B-12.59B-8.95B
Total Liabilities
230.68B231.42B244.60B250.86B212.76B219.40B
Stockholders Equity
145.49B149.08B139.52B128.04B118.29B111.44B
Cash FlowFree Cash Flow
0.0016.56B28.09B10.20B8.96B14.76B
Operating Cash Flow
0.0020.38B31.61B14.11B12.43B19.77B
Investing Cash Flow
0.00-4.03B-7.20B-6.77B-3.87B-19.29B
Financing Cash Flow
0.00-24.62B-20.48B-1.02B-8.84B-10.46B

Ship Healthcare Holdings Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1940.00
Price Trends
50DMA
1953.59
Negative
100DMA
1971.45
Negative
200DMA
2064.76
Negative
Market Momentum
MACD
-11.83
Negative
RSI
54.67
Neutral
STOCH
81.65
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3360, the sentiment is Neutral. The current price of 1940 is above the 20-day moving average (MA) of 1851.03, below the 50-day MA of 1953.59, and below the 200-day MA of 2064.76, indicating a neutral trend. The MACD of -11.83 indicates Negative momentum. The RSI at 54.67 is Neutral, neither overbought nor oversold. The STOCH value of 81.65 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3360.

Ship Healthcare Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$140.81B16.386.55%3.76%2.42%-13.12%
76
Outperform
¥119.65B19.82
2.63%11.54%-8.30%
73
Outperform
¥163.61B28.604.78%2.74%20.53%-75.16%
68
Neutral
¥183.04B12.1010.34%2.99%7.49%9.71%
64
Neutral
€210.72B41.212.07%2.03%9.85%-53.97%
63
Neutral
$55.24B57.621.87%2.04%0.10%-41.21%
54
Neutral
$5.38B3.31-45.11%3.29%16.82%0.04%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3360
Ship Healthcare Holdings
1,929.50
-301.93
-13.53%
JP:7730
Mani, Inc.
1,174.00
-677.47
-36.59%
JP:8086
Nipro
1,284.00
62.57
5.12%
JP:7716
Nakanishi
1,903.00
-444.96
-18.95%
JP:7817
Paramount Bed Holdings Co
2,608.00
-97.41
-3.60%
JP:3593
Hogy Medical Co
3,885.00
28.84
0.75%

Ship Healthcare Holdings Corporate Events

Ship Healthcare Holdings Announces Treasury Shares Cancellation
Jun 6, 2025

Ship Healthcare Holdings, Inc. has announced the cancellation of 7,319,266 treasury shares, representing 7.20% of its total shares, as part of a strategic move to optimize its capital structure. This cancellation, scheduled for June 30, 2025, will result in the company having no treasury shares, potentially enhancing shareholder value and improving financial metrics.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Announces Share Buyback Plan
Jun 6, 2025

Ship Healthcare Holdings has announced a plan to acquire up to 3,300,000 of its own shares, valued at up to 5 billion yen, as part of its medium-term management plan. This move aims to enhance shareholder returns, improve earnings per share, and achieve a targeted return on equity of 12%, reflecting the company’s strategic focus on balancing growth investments with shareholder returns.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Introduces Restricted Stock Compensation Plan
May 13, 2025

Ship Healthcare Holdings, Inc. has announced the adoption of a restricted stock compensation plan aimed at incentivizing its directors to enhance corporate value sustainably and align their interests with shareholders. This plan, which will be proposed at the upcoming General Meeting of Shareholders, involves granting restricted stocks to eligible directors, with a total annual limit of 35,000 shares or ¥60 million in compensation, separate from existing monetary compensation.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Announces Executive Personnel Changes
May 13, 2025

Ship Healthcare Holdings, Inc. announced changes in its executive personnel following a Board of Directors meeting. Hiroshi Yokoyama will be promoted to Executive Vice President, while Hisanori Fujioka will be appointed as a new Executive Officer. These changes are set to take effect on June 27, 2025, pending approval at the Ordinary General Meeting of Shareholders. The restructuring aims to strengthen the company’s leadership and enhance its strategic direction.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Announces Dividend Distribution Plan
May 13, 2025

Ship Healthcare Holdings, Inc. announced a resolution to distribute surplus dividends, with a basis date of March 31, 2025, which will be presented to shareholders in June. The company aims to maintain a dividend payout ratio of 30% or more, reflecting its commitment to returning profits while supporting business growth and strengthening management foundations.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

SHIP Healthcare Unveils ‘SHIP VISION 2030’ for Sustainable Growth
May 13, 2025

SHIP Healthcare Holdings has announced its new medium-term management plan, ‘SHIP VISION 2030’, which aims to enhance sustainable growth over the next five years. The plan focuses on optimizing group management resources and includes targets for sales growth, operating profit margin, and return on equity. The company plans to allocate significant funds for strategic investments and maintain a progressive dividend payout. Additionally, the plan emphasizes sustainability efforts, aiming to create value by addressing social issues and contributing to a well-being society.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Reports Stable Financial Growth for FY 2025
May 13, 2025

Ship Healthcare Holdings reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a 7.5% increase in net sales to ¥678,229 million and a 9.6% rise in profit attributable to owners of the parent. Despite a decrease in comprehensive income, the company improved its equity capital ratio to 39.1% and increased its annual dividend to ¥58.00 per share. These results indicate a stable financial performance and a commitment to shareholder returns, positioning the company favorably in the healthcare market.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.